First liquid chromatographic method for the simultaneous determination of amiodarone and desethylamiodarone in human plasma using microextraction by packed sorbent (MEPS) as sample preparation procedure

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 913-914, Issue , 2013, Pages 90-97

  Rodrigues, Márcio ^a,b,c   Alves, Gilberto ^b,c   Rocha, Marília ^b,d   Queiroz, João ^c   Falcão, Amílcar ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^d CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Amiodarone and desethylamiodarone; Bioanalytical method validation; HPLC; Human plasma; Microextraction by packed sorbent; Therapeutic drug monitoring

Indexed keywords

AMIODARONE; BIOANALYTICAL METHODS; HPLC; HUMAN PLASMAS; MICROEXTRACTION; THERAPEUTIC DRUG MONITORING;

CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; FORMIC ACID; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PATIENT MONITORING; PATIENT TREATMENT; PLASMA (HUMAN); SORPTION;

KETONES;

ACETONITRILE; AMIODARONE; DEETHYLAMIODARONE; FORMIC ACID; METHANOL; PHOSPHATE BUFFERED SALINE; TAMOXIFEN;

ANALYTIC METHOD; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STABILITY; DRUG STRUCTURE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MICROEXTRACTION BY PACKED SORBENT; PH; PRIORITY JOURNAL; VALIDATION PROCESS;

ADULT; AMIODARONE; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; DRUG STABILITY; FEMALE; HUMANS; LIMIT OF DETECTION; MALE; REPRODUCIBILITY OF RESULTS;

EID: 84872397093     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.11.028     Document Type: Article

References (50)

1. Wolkove N., Baltzan M. Can. Respir. J. 2009, 16:43.
2. Papiris S.A., Triantafillidou C., Kolilekas L., Markoulaki D., Manali E.D. Drug Saf. 2010, 33:539.
3. McKenna W.J., Rowland E., Krikler D.M., Br Med J. Clin. Res. Ed. 1983, 287:1654.
4. Veronese M.E., McLean S., Hendriks R. Br. J. Clin. Pharmacol. 1988, 26:721.
5. Campbell T.J., Williams K.M. Br. J. Clin. Pharmacol. 2001, 52(Suppl. 1):21S.
6. Seki S., Itagaki S., Kobayashi M., Hirano T., Iseki K. Biol. Pharm. Bull. 2008, 31:1449.
7. Lafuente-Lafuente C., Alvarez J.C., Leenhardt A., Mouly S., Extramiana F., Caulin C., Funck-Brentano C., Bergmann J.F. Br. J. Clin. Pharmacol. 2009, 67:511.
8. Stäubli M., Bircher J., Galeazzi R.L., Remund H., Studer H. Eur. J. Clin. Pharmacol. 1983, 24:485.
9. Pollak P.T., Bouillon T., Shafer S.L. Clin. Pharmacol. Ther. 2000, 67:642.
10. Lesne M., Pellegrin P.L. J. Chromatogr. 1987, 415:197.
11. Pérez-Ruiz T., Martínez-Lozano C., Sanz A., Bravo E. Chromatographia 2002, 56:63.
12. Shayeganpour A., Hamdy D.A., Brocks D.R. Biopharm. Drug Dispos. 2008, 29:159.
13. Rotmensch H.H., Belhassen B., Swanson B.N., Shoshani D., Spielman S.R., Greenspon A.J., Greenspan A.M., Vlasses P.H., Horowitz L.N. Ann. Intern. Med. 1984, 101:462.
14. Pollak P.T., Shafer S.L. Clin. Pharmacol. Ther. 2004, 75:342.
15. Rotmensch H.H., Swanson B.N., Greenspon A.J., Shoshani D., Greenspan A.M. Pacing Clin. Electrophysiol. 1983, 6:1327.
16. Kotake T., Takada M., Goto T., Komamura K., Kamakura S., Morishita H. J. Clin. Pharm. Ther. 2006, 31:237.
17. Sauro S.C., DeCarolis D.D., Pierpont G.L., Gornick C.C. Ann. Pharmacother. 2002, 36:1682.
18. Storey G.C., Holt D.W. J. Chromatogr. 1982, 245:377.
19. Gupta R.N., Connolly S. Clin. Chem. 1984, 30:1423.
20. Marchiset D., Aubert C., Sumirtapura Y.C., Egre A., Cano J.P. Eur. J. Drug Metab. Pharmacokinet. 1984, 9:123.
21. Shipe J.R. Clin. Chem. 1984, 30:1259.
22. Hutchings A., Spragg B.P., Routledge P.A. J. Chromatogr. 1986, 382:389.
23. De Smet M., Massart D.L. J. Pharm. Biomed. Anal. 1988, 6:277.
24. Paczkowski D., Poplawska W., Filipek M., Podleśny J. Pol. J. Pharmacol. Pharm. 1989, 41:359.
25. Rochas M.A., Caillard C., Coulais Y., Sqalli A., Houin G. Ann. Biol. Clin. (Paris) 1989, 47:135.
26. Juenke J.M., Brown P.I., McMillin G.A., Urry F.M. J. Anal. Toxicol. 2004, 28:63.
27. Susanto F., Humfeld S., Reinauer H. Chromatographia 1986, 22:135.
28. Verbesselt R., Tjandramaga T.B., De Schepper P.J. Ther. Drug Monit. 1991, 13:157.
29. Kollroser M., Schober C. J. Chromatogr. B 2002, 766:219.
30. Kuhn J., Götting C., Kleesiek K. J. Pharm. Biomed. Anal. 2010, 51:210.
31. Plomp T.A., Engels M., Robles de Medina E.O., Maes R.A. J. Chromatogr. 1983, 273:379.
32. Weir S.J., Ueda C.T. J. Pharm. Sci. 1985, 74:460.
33. Rajendran S.D., Madhusudan Rao Y., Thanikachlam S., Sathish K., Gopinath R., Arun K.P. Indian J. Pharm. Sci. 2006, 68:715.
34. Gumieniczek A., Misztal G., Przyborowski L. Acta Pol. Pharm. 1994, 51:325.
35. Bolderman R.W., Hermans J.J., Maessen J.G. J. Chromatogr. B 2009, 877:1727.
36. Chaves A.R., Leandro F.Z., Carris J.A., Queiroz M.E. J. Chromatogr. B 2010, 78:2123.
37. El-Beqqali A., Abdel-Rehim M. J. Sep. Sci. 2007, 30:2501.
38. El-Beqqali A., Kussak A., Blomberg L., Abdel-Rehim M. J. Liq. Chromatogr. Relat. Technol. 2007, 30:575.
39. Vlčková H., Solichová D., Bláha M., Solich P., Nováková L. J. Pharm. Biomed. Anal. 2011, 55:301.
40. Vlčková H., Rabatinová M., Mikšová A., Kolouchová G., Mičuda S., Solich P., Nováková L. Talanta 2012, 90:22.
41. Saracino M.A., Tallarico K., Raggi M.A. Anal. Chim. Acta 2010, 661:222.
42. Saracino M.A., de Palma A., Boncompagni G., Raggi M.A. Talanta 2010, 81:1547.
43. Mandrioli R., Mercolini L., Lateana D., Boncompagni G., Raggi M.A. J. Chromatogr. B 2011, 879:167.
44. Said R., Pohanka A., Andersson M., Beck O., Abdel-Rehim M. J. Chromatogr. B 2011, 879:815.
45. Abdel-Rehim M. J. Chromatogr. A 2010, 1217:2569.
46. Abdel-Rehim M. Anal. Chim. Acta 2011, 701:119.
47. Shah V.P., Midha K.K., Findlay J.W., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., Yacobi A. Pharm. Res. 2000, 17:1551.
48. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Rockville, USA, 2001. (Last access: 09.01.12). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatorInformation/Guidances/ucm070107.pdf.
49. Guideline on bioanalytical method validation, European Medicines Agency, EMEA/CHMP/EWP/192217/2009, Committee for Medicinal Products for Human Use (CHMP), 7 Westferry Circus, Canary Wharf, London E14 4HB, United Kingdom, 2011. (access: 09.01.2012). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
50. Almeida A.M., Castel-Branco M.M., Falcão A.C. J. Chromatogr. B 2002, 774:215.